Millipore Corporation awarded EU patent
Billerica, Massachusetts—Millipore Corporation, a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, announced that it was issued a European patent entitled, “Use of gamma hardened RFID tags in pharmaceutical devices.”
This patent covers systems and methods for using RFID tags in biopharmaceutical environments where gamma radiation is used for sterilization. The memory device within the tag utilizes a technology that is not affected by gamma radiation. RFID tags may be applied to various components during manufacturing or immediately after final assembly and can be subjected to a gamma sterilization without risk of data loss or corruption.
“We are pursuing this patent worldwide and expect to have it issued in the US, China, India, Singapore and Japan soon. By expanding our SMART technology RFID platform to be gamma compatible, we enable our customers to quickly access critical information about disposable process components that have been pre-sterilized,” says Jean-Paul Mangeolle, President, Bioprocess Division, Millipore Corporation.
The addition of this patent to the SMART technology portfolio means that these new RFID tags can now be utilized in Millipore’s Mobius® disposable solutions. With the increasing use of disposables, users can configure systems to meet their specific process requirements and eliminate costly cleaning operations. This new patented RFID technology can be reliably used on disposable components in a pharmaceutical and/or biotechnology manufacturing or research process.
“We’re excited to offer our customers improved ease-of-use, efficiency and accuracy by combining SMART and Mobius disposable technologies. Our new RFID tags can be affixed to single use filters, bags, tubes, process instruments, and other crucial components, allowing for a secure automated method of transferring unit specific information, without worry that the data may be lost or degraded during the sterilization process,” says Paul Chapman, Vice President, Downstream Processing, Bioprocess Division, Millipore Corporation.
About Millipore
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with 5,900 employees in 47 countries worldwide. For more information, please contact Millipore Tech Service at 1-800-548-7853 or 951-676-8080 or visit www.millipore.com.
ADVANCING LIFE SCIENCE TOGETHERTM
Research. Development. Production.
Press Contact:
Alex Paparsenos
Gray & Rice Public Relations
(617).367.0100 x 155
apaparsenos@gr2000.com
Millipore Media Contacts:
Janice E. Paquette
Director Global Marketing Communication
Bioprocess Division
781.533.5197
Janice_paquette@millipore.com
Shannon Meirzon
Marketing Communications Manager
Bioprocess Division
Millipore Corporation
781.533.2706
shannon_meirzon@millipore.com
Millipore and Mobius are registered trademarks and the “M” logo and ADVANCING LIFE SCIENCE TOGETHER are trademarks of Millipore Corporation.

